MedPath

Strides for Life I: Increasing Physical Activity in Stage 1 Lung Cancer Patients

Not Applicable
Completed
Conditions
Lung Cancer
Interventions
Behavioral: Physical activity plus positive affect
Behavioral: Physical activity plus education
Registration Number
NCT02755883
Lead Sponsor
Weill Medical College of Cornell University
Brief Summary

This randomized controlled trial will evaluate, among 54 stage early stage lung cancer patients, whether a behavioral intervention versus an educational Control group results in improved function at 6-months.

Detailed Description

This is a two arm randomized controlled trial that will evaluate, among 54 stage 1 non-small cell lung cancer patients, whether induction of positive affect vs. an educational Control group, results in improved function as assessed by the 6-minute Walk Test. Our primary outcome will be a within-patient change in the 6-Minute Walk Test at 6 months.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
29
Inclusion Criteria
  • Non-small cell lung cancer (Stage 1)
Read More
Exclusion Criteria
  1. Cognitive impairment
  2. Inability to walk
  3. < 12 month anticipated survival
  4. enrollment in other behavioral programs
  5. lack of medical approval to participate
  6. substance/alcohol dependence or participation in a substance abuse treatment program within 12 months
  7. major psychiatric illness.
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Physical activity plus positive affectPhysical activity plus positive affectSubjects will be randomized to a physical activity goal and the positive affect component
Physical activity plus educationPhysical activity plus educationSubjects will be randomized to a physical activity goal and education
Primary Outcome Measures
NameTimeMethod
Kilocalories/week assessed by 6-minute walk test1 month to 6 months
Secondary Outcome Measures
NameTimeMethod
Functional Assessment of Cancer Therapy- Lung (FACT-L14)1 month to 6 months

Disease-specific quality of life

Maximal Oxygen Consumption (VO2 max)1 month to 6 months

Pulmonary function test

Forced expiratory volume (FEV1)1 month to 6 months

Pulmonary function test

Activity expenditure (assessed by the Fit Bit Zip accelerometer)1 month to 6 months

Trial Locations

Locations (1)

Weill Cornell Medical College

🇺🇸

New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath